secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mobia Medical, Inc. (MOBI)
CIK:        0001489993
Form:       8-K
Filed at:   2026-08-11T20:12:00+00:00
Accession:  0001193125-26-344666
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mobia Medical Q2 revenue $13.5M (+102% YoY), net loss $21.0M; FY26 guide $54-56M
--------------------------------------------------------------------------------

- Revenue $13.5M vs $6.7M in Q2 2025, up 102%; gross margin 83.2% vs 82.3%.
- Net loss $21.0M ($1.10/share) vs $10.5M loss ($12.44/share) in prior year; per-share drop reflects IPO share conversion.
- Cash and equivalents $177.1M as of June 30, 2026; IPO closed May 2026 with ~$134.0M net proceeds.
- FY2026 revenue guidance $54-56M, implying 69-75% growth over 2025.
- Published two-year VNS-REHAB follow-up data in Neurology; appointed Myriam Curet, M.D. and Reza Zadno, Ph.D. to board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1489993/000119312526344666/0001193125-26-344666-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1489993/000119312526344666/mobi-20260811.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-344666

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer